Tianjin Lisheng Pharmaceutical Company Ltd.
力生制药
002393
Shenzhen Stock Exchange
Company Profile
1. Having a rather high reputation for its brand and quality and a high level of customer acceptance.The Company unremittingly improves its product quality and enhances its brand value. Through many years of efforts, Tianjin Lisheng Pharmaceutical Co., Ltd. has established its good product reputation and corporate image in the market, and its flagship product brand “Shoubishan” has long been well accepted by the public. The Shoubishan (“Indapamide Tablets”) is awarded again as “The Excellent Product Brand in the Chinese Chemical Pharmaceutical Industry 2017” at the ChemPharm Annual Summit 2017.2. Having a complete industrial chain with raw materials and preparations integrated.With a complete industrial chain, the Company itself produces all the raw materials needed for its main preparations. Thus the quality of the preparations is guaranteed from the source, and production costs and pollutant emissions are effectively reduced through an increased yield.3. Excellent commercial channels.The Company has already forged strategic partnerships with China Resources, Sinopharm, and Jointown Pharmaceutical Group Limited. Its distribution channels spread across the country, and the development of its clinical products has begun to take shape as well.4. A wide diversity of products.The Company and its wholly-owned subsidiaries have 15 main categories and 243 approval numbers of products.5. The advantage as a listed company.As a listed company, the Company has alternative financing sources or channels, ample funds, and strong anti-risk capabilities.
Full description
Tianjin Lisheng Pharmaceutical Co., Ltd., whose predecessor was the Tianjin Lisheng Pharmaceutical Plant initially built in 1951, already has a history of over 60 years so far. Tianjin Lisheng Pharmaceutical Co., Ltd. was established after having been officially restructured as approved by the Tianjin Municipal Government on August 8, 2001, and was successfully listed on the Shenzhen Stock Exchange in April 2010. Main products of Tianjin Lisheng Pharmaceutical Co., Ltd. include: traditional Chinese medicine and Western medicine tablets, hard capsules, granules, drop pills,lyophilized powder for injection,water injection and active pharmaceutical ingredients. Marketing network of Tianjin Lisheng Pharmaceutical Co., Ltd. covers the entire country, and some of its products are also exported to foreign countries or regions such as Japan, Australia, etc.Tianjin Lisheng Pharmaceutical Co., Ltd. invested 845 million yuan in building a new plant in Xiqing Economic Development Area in 2012, which covers an area of 20 hectares. Relocated to the new plant in 2016, Tianjin Lisheng Pharmaceutical Co., Ltd. has an annual production capacity of 10 billion tablets.Tianjin Lisheng Pharmaceutical Co., Ltd. now has two wholly-owned subsidiaries and five joint-stock companies. The two wholly-owned subsidiaries of Tianjin Lisheng Pharmaceutical Co., Ltd. are Tianjin Central Pharmaceutical Co., Ltd. (below “Central Pharmaceutical” for short) and Tianjin Biochemical Pharmaceutical Co., Ltd. (below “Biochemical Pharmaceutical” for short); the five joint-stock companies are Tianjin Pharmaceutical Group Finance Co., Ltd., Tianjin Tanabe Seiyaku Co., Ltd., Tianjin Shin Uchida Pharmaceutical Co., Ltd., Tianjin ROHTO Herbal Medicine Co., Ltd., and Tasly Holding Group Co., Ltd. Tianjin Lisheng Pharmaceutical Co., Ltd. and its subsidiaries Biochemical Pharmaceutical and Central Pharmaceutical are all officially identified as high-tech enterprises, and enjoy the preferential 15% income tax rate.Tianjin Lisheng Pharmaceutical Co., Ltd. and its wholly-owned subsidiaries have its main products as follows: Indapamide tablets, Paracetamol, Caffeine and aspirin tablets, Nanbao capsules, Gaviscon tablets, Aspirin enteric capsules, Itraconazole capsules, Olsalazine sodium capsules, Donepezil hydrochloride tablets, Cefdinir dispersible tablets, Cefaclor sustained-release tablets, Nimodipine tablets, Atenolol tablets, Ciprofloxacin tablets, Maren soft capsules, Vitamin E soft capsules, Guanxinsuhe soft capsules, Cyclosporine soft capsules, Oenothera Biennis Oil soft capsules, Methadone hydrochloride oral solution, Hydrocortisone sodium succinate for injection, Urokinase for injection, Amikacin sulfate for injection, Azithromycin maleate for injection, Heparin sodium injection, Nadroparin calcium injection, Heparin calcium injection, Azithromycin maleate injection, Ocular extractives injection, Citicoline sodium injection, etc.